Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEROHCA
NCT04624776Phase 2Completed
- Start
- Oct 2020
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of methylprednisolone injection in cardiac arrest (SCA) and post-cardiac arrest syndrome (PCAS) (2 arms). Primary endpoints: Concentration of Interleukin-6 and Concentration of Neuron-Specific Enolase. Started Oct 2020; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
cardiac arrest (SCA)post-cardiac arrest syndrome (PCAS)
Beyond the preview
Go deeper on NCT04624776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04624776.